Vivus Sinks After Diet Drug Ingredient Linked to Oral Clefts – BusinessWeek

Vivus Sinks After Diet Drug Ingredient Linked to Oral Clefts
BusinessWeek
22 (Bloomberg) — Vivus Inc., maker of an experimental weight-loss pill, plunged 20 percent in early trading after an ingredient in the medicine was shown to be associated with oral clefts in babies whose mothers took it in pregnancy.
Vivus Drops as Diet Drug Ingredient Affiliated With DefectsBloomberg
The Consumer Justice Foundation Alerts the Public of the Drop in Stock Value PR Web (press release)
Vivus sinks after delivering oral cleft data on obesity drug ingredientFierceBiotech
MarketWatch (press release)
all 32 news articles »

View full post on Diet Weight Loss – Google News

, , , , , , , , ,

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Get Adobe Flash player
SEO Powered by Platinum SEO from Techblissonline
© 1992-2012 DC2NET™, Inc. All Rights Reserved